Authors:
Mas, R
Castano, G
Fernandez, L
Illnait, J
Fernandez, J
Alvarez, E
Citation: R. Mas et al., Effects of policosanol on lipid profile and cardiac events in older hypercholesterolaemic patients with coronary disease, CLIN DRUG I, 21(7), 2001, pp. 485-497
Authors:
Castano, G
Mas, R
Fernandez, JC
Illnait, J
Fernandez, L
Alvarez, E
Citation: G. Castano et al., Effects of policosanol in older patients with type II hypercholesterolemiaand high coronary risk, J GERONT A, 56(3), 2001, pp. M186-M192
Authors:
Sookoian, S
Castano, G
Frider, B
Cello, J
Campos, R
Flichman, D
Citation: S. Sookoian et al., Combined therapy with interferon and ribavirin in chronic hepatitis C doesnot affect serum quasispecies diversity, DIG DIS SCI, 46(5), 2001, pp. 1067-1071
Authors:
Castano, G
Mas, R
Fernandez, L
Illnait, J
Gamez, R
Fernandez, JC
Citation: G. Castano et al., Comparison of two regimens of policosanol administered at 20 mg/d in patients with type II hypercholesterolemia: A randomized, double-blind, placebo-controlled study, CURR THER R, 62(3), 2001, pp. 194-208
Authors:
Mendoza, S
Gamez, R
Noa, M
Mas, R
Castano, G
Mesa, R
Mesa, M
de Armas, M
Citation: S. Mendoza et al., Comparison of the effects of D-003 and policosanol on lipid profile and endothelial cells in normocholesterolemic rabbits, CURR THER R, 62(3), 2001, pp. 209-220
Authors:
Sookoian, S
Flichman, D
Castano, G
Frider, B
Campos, R
Citation: S. Sookoian et al., Relationship between diversity of hepatitis C quasispecies and histological severity of liver disease, MEDICINA, 60(5), 2000, pp. 587-590
Authors:
Castano, G
Mas, R
Fernandez, JC
Fernandez, L
Alvarez, E
Lezcay, M
Citation: G. Castano et al., Efficacy and tolerability of policosanol compared with lovastatin in patients with type II hypercholesterolemia and concomitant coronary risk factors, CURR THER R, 61(3), 2000, pp. 137-146
Authors:
Castano, G
Mas, R
Fernandez, JC
Lopez, LE
Fernandez, L
Citation: G. Castano et al., A long-term, open-label study of the efficacy and tolerability of policosanol in patients with high global coronary risk, CURR THER R, 60(7), 1999, pp. 379-391
Authors:
Mas, R
Castano, G
Illnait, J
Fernandez, L
Fernandez, J
Aleman, C
Pontigas, V
Lescay, M
Citation: R. Mas et al., Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors, CLIN PHARM, 65(4), 1999, pp. 439-447
Authors:
Sookoian, S
Neglia, V
Castano, G
Frider, B
Kien, MC
Chohuela, E
Citation: S. Sookoian et al., High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus, ARCH DERMAT, 135(8), 1999, pp. 1000-1001
Authors:
Castano, G
Mas, R
Roca, J
Fernandez, L
Illnait, J
Fernandez, JC
Selman, E
Citation: G. Castano et al., A double-blind, placebo-controlled study of the effects of policosanol in patients with intermittent claudication, ANGIOLOGY, 50(2), 1999, pp. 123-130